Neurology® Podcast

In part one of this two-part series, Dr. Dan Ackerman talks with Drs. Valérie Biousse and Nancy J. Newman about the clinical presentations, diagnostic challenges, and the importance of accurate diagnosis in managing CRAO and BRAO. Read the article referenced in this interview in the Journal of Stroke & Cerebrovascular Diseases. Disclosures can be found at Neurology.org.

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about the highlights from the 17th World Stroke Congress. Learn more on the World Stroke Congress website. Disclosures can be found at Neurology.org.

Dr. Kristen Dams-O'Connor, a clinician-scientist at the Icahn School of Medicine, explores traumatic encephalopathy syndrome (TES) linked to traumatic brain injuries. She discusses the long-term outcomes of TBI and clarifies the distinction between clinical features of TES and pathologies like CTE. Kristen outlines her research in the LETBI cohort, highlighting that about 34% of participants met TES core criteria even without repetitive head impacts. She emphasizes the need for improved diagnostics and a multidisciplinary approach to treatment.

Dr. Jeff Ratliff talks with Dr. Dara Albert about the misconceptions surrounding FND, the importance of compassionate communication with patients, and the need for improved educational strategies to address knowledge gaps. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org.

In this insightful discussion, Janis Miyasaki, a neurology division director and palliative care advocate, shares her journey and the importance of patient-centered approaches in integrating palliative care into neurology. Miranda Wan, a stroke fellow, reveals barriers neurologists face in conversations about palliative care, emphasizing cultural and training deficiencies. Carolyn Reynolds, a palliative care physician, examines the motivations of ALS patients considering medical aid in dying, highlighting emotional suffering and the critical role of caregivers. This dialogue sparks vital reflections on compassionate end-of-life care.

Dr. Alex Menze talks with Professor Hakan Cetin about the need to reevaluate the approach to diagnosing and treating seronegative myasthenia gravis. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

Dr. Gregg Day talks with Professor Jonathan Rohrer about the significance of studying individuals at risk of developing genetic frontotemporal dementia, focusing on how early cognitive changes before symptoms appear can inform research and future therapeutic trials. Read the related article in Neurology®Genetics. Disclosures can be found at Neurology.org.

Dr. YuHong Fu, a neuroscientist from the University of Sydney, dives into the critical distinctions between dementia with Lewy bodies and Parkinson disease dementia. She highlights the unique clinical symptoms, such as fluctuating attention and hallucinations in DLB. Fu discusses how understanding these differences not only aids in diagnosis but also influences treatment strategies. She touches on biomarkers like DaT scans and emerging assays, emphasizing their roles in tailoring personalized care for patients.

Dr. Dan Ackerman talks with Dr. Isabel Hostettler about the diagnosis, risk factors, and prognosis of RCVS, highlighting the need to recognize symptoms and distinguish it from other causes of subarachnoid hemorrhage. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

In a special episode of the Neurology Podcast, Dr. Stacey Clardy discusses how AI is shaping various aspects of our lives, including podcasts. Read the related article in Neurology® Open Access. Disclosures can be found at Neurology.org.